Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2019-05-13 Declaration of Voting R…
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Results of 2019 Annual General Meeting 4 pages 200.0KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement dated 14 May 2019, titled 'RESULTS OF ANNUAL GENERAL MEETING'. It details the resolutions and the proxy and poll voting results for each resolution at the AGM. The content includes voting outcomes for director elections, share placements, option approvals, and remuneration report adoption. There is no financial data or report content, only the official voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is 5380 characters, sufficient to contain detailed voting results rather than a brief notice. Therefore, the correct classification is DVA with high confidence.
2019-05-13 English
Admedus to divest part of Infusion business 2 pages 121.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 13 May 2019 regarding Admedus Ltd's agreement to divest part of its Infusion business. It details the terms of the sale, expected completion, and strategic rationale behind the divestiture. The content focuses on a corporate transaction (divestiture) and restructuring plans, including financial terms and operational impacts. There is no detailed financial report, earnings data, or regulatory filing referenced. The document is a corporate announcement about a capital transaction rather than a full financial report or earnings release. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 3361 characters, which is consistent with an announcement rather than a full report.
2019-05-12 English
BTC: BTC health to acquire Hospital Infusion Business 2 pages 49.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 13 May 2019 from BTC health regarding the acquisition of a hospital infusion business. It details the terms of the acquisition, including purchase price, forecast revenues, and strategic rationale. The content focuses on a corporate transaction and financing plans (capital raise through private placement and share purchase plan) to fund the acquisition. There are no financial statements, quarterly or annual results, or regulatory certifications included. The document is an update on a capital transaction and financing activity rather than a full financial report or earnings release. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-05-12 English
Facility Agreement with SIO Partners LP 2 pages 119.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 8 May 2019 regarding a facility agreement signed between Admedus Ltd and SIO Partners, LP for a secured debt facility of A$1 million. The content focuses on the terms of the debt facility, including interest rate, fees, repayment, and potential conversion to shares. It also mentions the purpose of the funds and the company's operational plans. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is a financing update about a new debt facility, which fits the category of Capital/Financing Update (CAP). The document length is 2932 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is CAP with high confidence.
2019-05-07 English
Extension for Voluntary Suspension 1 page 78.5KB
Regulatory Filings Classification · 95% confidence The document is a letter from Admedus Limited to the ASX Listings Compliance regarding an extension for voluntary suspension of trading of its securities. It references Listing Rule 17.2 and discusses the suspension period and reasons for the suspension related to the company's recapitalisation plan. The document is short (1752 characters) and is an announcement about a trading suspension, not a financial report or detailed filing. It does not contain financial statements, audit information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-05-06 English
Appendix 4C - quarterly 8 pages 275.6KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'QUARTERLY REPORT – APPENDIX 4C FOR THE PERIOD TO 31 MARCH 2019' and contains detailed financial data including cash flow statements for the quarter ended 31 March 2019. It includes operating, investing, and financing cash flows, as well as narrative commentary on business performance, sales, and corporate activities. The presence of detailed financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document is approximately 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2019
2019-04-25 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.